221 related articles for article (PubMed ID: 21776025)
1. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells.
Cheng B; Ling C; Dai Y; Lu Y; Glushakova LG; Gee SW; McGoogan KE; Aslanidi GV; Park M; Stacpoole PW; Siemann D; Liu C; Srivastava A; Ling C
Gene Ther; 2012 Apr; 19(4):375-84. PubMed ID: 21776025
[TBL] [Abstract][Full Text] [Related]
2. High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors.
Ling C; Lu Y; Cheng B; McGoogan KE; Gee SW; Ma W; Li B; Aslanidi GV; Srivastava A
J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445055
[TBL] [Abstract][Full Text] [Related]
3. Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3.
Ling C; Lu Y; Kalsi JK; Jayandharan GR; Li B; Ma W; Cheng B; Gee SW; McGoogan KE; Govindasamy L; Zhong L; Agbandje-McKenna M; Srivastava A
Hum Gene Ther; 2010 Dec; 21(12):1741-7. PubMed ID: 20545554
[TBL] [Abstract][Full Text] [Related]
4. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo.
Yin L; Keeler GD; Zhang Y; Hoffman BE; Ling C; Qing K; Srivastava A
Gene Ther; 2021 Aug; 28(7-8):422-434. PubMed ID: 32152434
[TBL] [Abstract][Full Text] [Related]
5. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.
Zhong L; Li B; Mah CS; Govindasamy L; Agbandje-McKenna M; Cooper M; Herzog RW; Zolotukhin I; Warrington KH; Weigel-Van Aken KA; Hobbs JA; Zolotukhin S; Muzyczka N; Srivastava A
Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7827-32. PubMed ID: 18511559
[TBL] [Abstract][Full Text] [Related]
6. High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo.
Song L; Li X; Jayandharan GR; Wang Y; Aslanidi GV; Ling C; Zhong L; Gao G; Yoder MC; Ling C; Tan M; Srivastava A
PLoS One; 2013; 8(3):e58757. PubMed ID: 23516552
[TBL] [Abstract][Full Text] [Related]
7. Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses.
Ling C; Li B; Ma W; Srivastava A
Hum Gene Ther Methods; 2016 Aug; 27(4):143-9. PubMed ID: 27431826
[TBL] [Abstract][Full Text] [Related]
8. Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model.
Ling C; Wang Y; Zhang Y; Ejjigani A; Yin Z; Lu Y; Wang L; Wang M; Li J; Hu Z; Aslanidi GV; Zhong L; Gao G; Srivastava A; Ling C
Hum Gene Ther; 2014 Dec; 25(12):1023-34. PubMed ID: 25296041
[TBL] [Abstract][Full Text] [Related]
9. Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors.
Ling C; Yin Z; Li J; Zhang D; Aslanidi G; Srivastava A
Mol Ther Methods Clin Dev; 2016; 3():16029. PubMed ID: 27200382
[TBL] [Abstract][Full Text] [Related]
10. Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B.
Brown HC; Doering CB; Herzog RW; Ling C; Markusic DM; Spencer HT; Srivastava A; Srivastava A
Hum Gene Ther; 2020 Oct; 31(19-20):1114-1123. PubMed ID: 32657150
[TBL] [Abstract][Full Text] [Related]
11. Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors.
Chen M; Maeng K; Nawab A; Francois RA; Bray JK; Reinhard MK; Boye SL; Hauswirth WW; Kaye FJ; Aslanidi G; Srivastava A; Zajac-Kaye M
Hum Gene Ther Methods; 2017 Feb; 28(1):49-59. PubMed ID: 28125909
[TBL] [Abstract][Full Text] [Related]
12. High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy.
Li M; Jayandharan GR; Li B; Ling C; Ma W; Srivastava A; Zhong L
Hum Gene Ther; 2010 Nov; 21(11):1527-43. PubMed ID: 20507237
[TBL] [Abstract][Full Text] [Related]
13. Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells.
Sayroo R; Nolasco D; Yin Z; Colon-Cortes Y; Pandya M; Ling C; Aslanidi G
Gene Ther; 2016 Jan; 23(1):18-25. PubMed ID: 26270885
[TBL] [Abstract][Full Text] [Related]
14. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
[TBL] [Abstract][Full Text] [Related]
15. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
[TBL] [Abstract][Full Text] [Related]
16. Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines.
Ryals RC; Boye SL; Dinculescu A; Hauswirth WW; Boye SE
Mol Vis; 2011 Apr; 17():1090-102. PubMed ID: 21552473
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.
Song L; Kauss MA; Kopin E; Chandra M; Ul-Hasan T; Miller E; Jayandharan GR; Rivers AE; Aslanidi GV; Ling C; Li B; Ma W; Li X; Andino LM; Zhong L; Tarantal AF; Yoder MC; Wong KK; Tan M; Chatterjee S; Srivastava A
Cytotherapy; 2013 Aug; 15(8):986-98. PubMed ID: 23830234
[TBL] [Abstract][Full Text] [Related]
18. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.
Rutledge EA; Halbert CL; Russell DW
J Virol; 1998 Jan; 72(1):309-19. PubMed ID: 9420229
[TBL] [Abstract][Full Text] [Related]
19. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
[TBL] [Abstract][Full Text] [Related]
20. Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.
Li S; Ling C; Zhong L; Li M; Su Q; He R; Tang Q; Greiner DL; Shultz LD; Brehm MA; Flotte TR; Mueller C; Srivastava A; Gao G
Mol Ther; 2015 Dec; 23(12):1867-76. PubMed ID: 26403887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
